GENE ONLINE|News &
Opinion
Blog

Cancer
Lilly Bets $2 Billion on Kumquat Biosciences for Novel Immune-Oncology Therapeutics
2021-07-31
The Evolution of Cytokine Therapies for a Broad Spectrum of Disorders
2021-07-30
Pfizer Inks Second Collaboration with Arvinas, Makes Billion-Dollar Investment on a Novel Agent for Breast Cancer Therapy
2021-07-26
The Future of Precision Medicine: From Gene Therapy to Data Sharing Boom – Excerpts from the US-Taiwan Precision Medicine Forum
2021-07-21
FoundationOne CDx Okayed as Companion Diagnostic for Takeda’s Lung Cancer Drug
2021-07-04
NHS To Trial GRAIL’s Blood Test That Can Accurately Detect Over 50 Cancers at Early Stages
2021-07-01
AbbVie to Acquire TeneoOne and Its Lead Multiple Myeloma Drug
2021-06-27
Genomic Profiling Reveals Multiple Resistance Mechanisms of Cancers Against KRAS Inhibitors
2021-06-25
Alibaba Health, Berry Oncology Expand Scale of Early Cancer Detection in China
2021-06-23
Extracting Clinical Information from Cancer Genomics
2021-06-10
New IO Targets and Resistance Mechanisms of Immune Checkpoint-Based Therapies
2021-06-10
#ASCO21: Large Cohort Study by Foundation Medicine and Collaborators Reveal Disparities in Precision Cancer Care
2021-06-09
Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies
2021-06-09
Day 3 ASCO 2021 Roundup: Lynparza, Keytruda and Novartis’ Radioligand Therapy Take Honors in Plenary Session
2021-06-09
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
1 2 3 15
LATEST
A Boom in High-Value M&A and Licensing Deals in the Exosome Field
2021-08-03
Game-Changer in Malaria Prevention: CRISPR-Based Genetic Engineering May Eradicate Malaria Vector Anopheles
2021-08-03
Realizing The Promise of Cell And Gene Therapies: Current Challenges And Future Opportunities
2021-08-02
Germline Editing in Marsupials Marks Another Milestone for CRISPR
2021-08-01
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
Amgen Acquires Teneobio to Snag New Class of Antibody Therapies
2021-07-31
Takeda Signs New Deal with PeptiDream Spending Billions to Develop Neuromuscular Disease Drugs
2021-07-30
Scroll to Top

Subscribe To Our News

Keep yourself updated at all times!